DOUGLAS P ZIPES, M.D.
Osteopathic Medicine at Capitol Ave, Indianapolis, IN

License number
Indiana 01023557
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
1801 N Capitol Ave, Indianapolis, IN 46202
Phone
(317) 962-0556

Personal information

See more information about DOUGLAS P ZIPES at radaris.com
Name
Address
Phone
Douglas Zipes, age 85
10614 Winterwood, Carmel, IN 46032
Douglas P Zipes, age 85
10614 Winterwood, Carmel, IN 46032
(317) 843-0222
Douglas Zipes
250 38Th St, Indianapolis, IN 46205

Professional information

Douglas P Zipes Photo 1

Dr. Douglas P Zipes, Indianapolis IN - MD (Doctor of Medicine)

Specialties:
Cardiology, Clinical Cardiac Electrophysiology
Address:
Krannert Institute Cardiology
1801 Senate Blvd SUITE 4000, Indianapolis 46202
(317) 962-0500 (Phone)
Certifications:
Cardiovascular Disease, 1972, Clinical Cardiac Electrophysiology, 1998, Internal Medicine, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Krannert Institute Cardiology
1801 Senate Blvd SUITE 4000, Indianapolis 46202
Hendricks Regional Health
1000 East Main St, Danville 46122
Community Hospital North
7150 Clearvista Dr, Indianapolis 46256
Education:
Medical School
Harvard Medical School
Graduated: 1964
Duke University Hospital
Graduated: 1965
Graduated: 1966
Graduated: 1968


Douglas Zipes Photo 2

Author At Iupui

Position:
Distinguished Professor at Indiana University School of Medicine, author at IUPUI, MACC at American College of Cardiology
Location:
Indianapolis, Indiana Area
Industry:
Health, Wellness and Fitness
Work:
Indiana University School of Medicine - Distinguished Professor IUPUI since Jan 2010 - author American College of Cardiology since 1972 - MACC


Douglas Zipes Photo 3

Method Of Inhibiting Cardiac Arrhythmias

US Patent:
4554922, Nov 26, 1985
Filed:
Sep 30, 1982
Appl. No.:
6/429827
Inventors:
Eric N. Prystowsky - Indianapolis IN
Douglas P. Zipes - Indianapolis IN
International Classification:
A61N 136
US Classification:
128419PG
Abstract:
Inhibition of cardiac arrhythmias such as tachycardia and fibrillation is achieved by determining a refractory period after a selected heartbeat during which a stimulus applied to the heart will not propagate a heart response, determining a time within the refractory period after the selected heartbeat for the application of one or more electrical pulses to the heart to inhibit arrhythmic beats, determining a voltage of the electrical pulse as a function of the time which will inhibit the arrhythmic beats, and applying the electrical pulse to an area of the heart at the determined time to inhibit the arrhythmic beats. A plurality of electrical pulses may be employed having various voltage levels related to the times at which they are applied during the refractory period. One or more electrical pulses may be applied after the refractory period, each having a voltage providing a current less than a threshold current which would propagate a heart response.


Douglas Peter Zipes Photo 4

Douglas Peter Zipes, Indianapolis IN

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
Clarian Health Partners, Incorporated
1801 Senate Blvd, Indianapolis, IN 46202 Clarian Health Partners, Incorporated
1701 Senate Blvd, Indianapolis, IN 46202 Cardiovascular Diagnostic Services
1701 N Capitol Ave, Indianapolis, IN 46202 Indiana University Medical Group
200 W 103Rd St, Indianapolis, IN 46290
Education:
Harvard University(1964)


Douglas Zipes Photo 5

Synchronous Intracardiac Cardioverter

US Patent:
4384585, May 24, 1983
Filed:
Mar 6, 1981
Appl. No.:
6/241314
Inventors:
Douglas P. Zipes - Indianapolis IN
Assignee:
Medtronic, Inc. - Minneapolis MN
International Classification:
A61N 136
US Classification:
128419D
Abstract:
An implantable medical device to deliver cardioverting energy to cardiac tissue in synchrony with detected ventricular depolarizations. The energy renders refractory, areas of the heart associated with a reciprocating or automatic tachycardia, thus reverting these tachyarrhythmias to normal sinus rhythm without the risk of stimulating the heart during the vulnerable portion of repolarization.